Clinical Trial Update: Golidocitinib Plus CHOP in Newly Diagnosed PTCL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating golidocitinib plus CHOP for newly diagnosed peripheral T-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Golidocitinib (golidocitinib)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Peripheral T-cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING